These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats. Yang XM, Gorman AL, Dunn AJ. J Pharmacol Exp Ther; 1990 Dec 29; 255(3):1064-70. PubMed ID: 2262892 [Abstract] [Full Text] [Related]
11. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol. Dagnault A, Ouerghi D, Richard D. Brain Res Bull; 1993 Dec 29; 32(6):689-92. PubMed ID: 8221168 [Abstract] [Full Text] [Related]
12. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. J Neurosci; 1994 May 29; 14(5 Pt 1):2579-84. PubMed ID: 8182429 [Abstract] [Full Text] [Related]
13. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Sütö G, Király A, Taché Y. Gastroenterology; 1994 Jun 29; 106(6):1568-75. PubMed ID: 8194703 [Abstract] [Full Text] [Related]
14. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor. Brown MR, Carver-Moore K, Gray TS, Rivier C. Endocrinology; 1989 Nov 29; 125(5):2558-62. PubMed ID: 2551657 [Abstract] [Full Text] [Related]
15. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Neuropsychopharmacology; 2000 Mar 29; 22(3):230-9. PubMed ID: 10693150 [Abstract] [Full Text] [Related]
16. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat. Rothwell NJ. Am J Physiol; 1989 Jan 29; 256(1 Pt 1):E111-5. PubMed ID: 2783532 [Abstract] [Full Text] [Related]
17. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. Berridge CW, Dunn AJ. J Neurosci; 1989 Oct 29; 9(10):3513-21. PubMed ID: 2795137 [Abstract] [Full Text] [Related]
18. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41. Conti LH, Costello DG, Martin LA, White MF, Abreu ME. Pharmacol Biochem Behav; 1994 Jun 29; 48(2):497-503. PubMed ID: 8090821 [Abstract] [Full Text] [Related]
19. Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice. Kita A, Imano K, Nakamura H. Eur J Pharmacol; 1993 Jun 24; 237(2-3):317-22. PubMed ID: 8365458 [Abstract] [Full Text] [Related]
20. Central interleukin-1 beta enhances splenic sympathetic nerve activity in rats. Ichijo T, Katafuchi T, Hori T. Brain Res Bull; 1994 Jun 24; 34(6):547-53. PubMed ID: 7922597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]